AAAAAA

   
Results: 1-17 |
Results: 17
EXPRESSION OF STEM-CELL FACTOR-RECEPTOR (C-KIT) BY THE MALIGNANT MAST-CELLS FROM SPONTANEOUS CANINE MAST-CELL TUMORS
Authors: LONDON CA KISSEBERTH WC GALLI SJ GEISSLER EN HELFAND SC
Citation: Ca. London et al., EXPRESSION OF STEM-CELL FACTOR-RECEPTOR (C-KIT) BY THE MALIGNANT MAST-CELLS FROM SPONTANEOUS CANINE MAST-CELL TUMORS, Journal of Comparative Pathology, 115(4), 1996, pp. 399-414
LYSIS OF HUMAN TUMOR-CELL LINES BY CANINE COMPLEMENT PLUS MONOCLONAL ANTIGANGLIOSIDE ANTIBODIES OR NATURAL CANINE XENOANTIBODIES
Authors: HELFAND SC HANK JA GAN J SONDEL PM
Citation: Sc. Helfand et al., LYSIS OF HUMAN TUMOR-CELL LINES BY CANINE COMPLEMENT PLUS MONOCLONAL ANTIGANGLIOSIDE ANTIBODIES OR NATURAL CANINE XENOANTIBODIES, Cellular immunology, 167(1), 1996, pp. 99-107
ADJUVANT THERAPY FOR OSTEOSARCOMA IN DOGS - RESULTS OF RANDOMIZED CLINICAL-TRIALS USING COMBINED LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE AND CISPLATIN
Authors: KURZMAN ID MACEWEN EG ROSENTHAL RC FOX LE KELLER ET HELFAND SC VAIL DM DUBIELZIG RR MADEWELL BR RODRIGUEZ CO OBRADOVICH J FIDEL J ROSENBERG M
Citation: Id. Kurzman et al., ADJUVANT THERAPY FOR OSTEOSARCOMA IN DOGS - RESULTS OF RANDOMIZED CLINICAL-TRIALS USING COMBINED LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE AND CISPLATIN, Clinical cancer research, 1(12), 1995, pp. 1595-1601
LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE ADJUVANT IMMUNOTHERAPY FOR SPLENIC HEMANGIOSARCOMA IN THE DOG - A RANDOMIZED MULTIINSTITUTIONAL CLINICAL-TRIAL
Authors: VAIL DM MACEWEN EG KURZMAN ID DUBIELZIG RR HELFAND SC KISSEBERTH WC LONDON CA OBRADOVICH JE MADEWELL BR RODRIGUEZ CO FIDEL J SUSANECK S ROSENBERG M
Citation: Dm. Vail et al., LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE ADJUVANT IMMUNOTHERAPY FOR SPLENIC HEMANGIOSARCOMA IN THE DOG - A RANDOMIZED MULTIINSTITUTIONAL CLINICAL-TRIAL, Clinical cancer research, 1(10), 1995, pp. 1165-1170
LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE FORTHE TREATMENT OF FELINE MAMMARY ADENOCARCINOMA - A MULTICENTER RANDOMIZED DOUBLE-BLIND-STUDY
Authors: FOX LE MACEWEN EG KURZMAN ID DUBIELZIG RR HELFAND SC VAIL DM KISSEBERTH W LONDON C MADEWELL BR RODRIGUEZ CO JEGLUM KA ROSENBERG M ROSENTHAL RC
Citation: Le. Fox et al., LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE FORTHE TREATMENT OF FELINE MAMMARY ADENOCARCINOMA - A MULTICENTER RANDOMIZED DOUBLE-BLIND-STUDY, Cancer biotherapy, 10(2), 1995, pp. 125-130
RESPONSE TO LIPOSOME-ENCAPSULATED DOXORUBICIN (TLC D-99) IN A DOG WITH MYELOMA
Authors: KISSEBERTH WC MACEWEN EG HELFAND SC VAIL DM LONDON CL KELLER E
Citation: Wc. Kisseberth et al., RESPONSE TO LIPOSOME-ENCAPSULATED DOXORUBICIN (TLC D-99) IN A DOG WITH MYELOMA, Journal of veterinary internal medicine, 9(6), 1995, pp. 425-428
ACUTE EFFECTS OF CONTINUOUS INFUSIONS OF HUMAN RECOMBINANT INTERLEUKIN-2 ON SERUM THYROID-HORMONE CONCENTRATIONS IN DOGS
Authors: PANCIERA DL HELFAND SC SOERGEL SA
Citation: Dl. Panciera et al., ACUTE EFFECTS OF CONTINUOUS INFUSIONS OF HUMAN RECOMBINANT INTERLEUKIN-2 ON SERUM THYROID-HORMONE CONCENTRATIONS IN DOGS, Research in Veterinary Science, 58(1), 1995, pp. 96-97
FUNCTIONAL INTERLEUKIN-2 RECEPTORS ARE EXPRESSED ON NATURAL KILLER-LIKE LEUKEMIC-CELLS FROM A DOG WITH CUTANEOUS LYMPHOMA
Authors: HELFAND SC MODIANO JF MOORE PF SOERGEL SA MACWILLIAMS PS DUBIELZIG RD HANK JA GELFAND EW SONDEL PM
Citation: Sc. Helfand et al., FUNCTIONAL INTERLEUKIN-2 RECEPTORS ARE EXPRESSED ON NATURAL KILLER-LIKE LEUKEMIC-CELLS FROM A DOG WITH CUTANEOUS LYMPHOMA, Blood, 86(2), 1995, pp. 636-645
POTENTIAL TO INVOLVE MULTIPLE EFFECTOR-CELLS WITH HUMAN RECOMBINANT INTERLEUKIN-2 AND ANTIGANGLIOSIDE MONOCLONAL-ANTIBODIES IN A CANINE MALIGNANT-MELANOMA IMMUNOTHERAPY MODEL
Authors: HELFAND SC SOERGEL SA DONNER RL GAN J HANK JA LINDSTROM MJ SONDEL PM
Citation: Sc. Helfand et al., POTENTIAL TO INVOLVE MULTIPLE EFFECTOR-CELLS WITH HUMAN RECOMBINANT INTERLEUKIN-2 AND ANTIGANGLIOSIDE MONOCLONAL-ANTIBODIES IN A CANINE MALIGNANT-MELANOMA IMMUNOTHERAPY MODEL, Journal of immunotherapy with emphasis on tumor immunology, 16(3), 1994, pp. 188-197
INDUCTION OF LYMPHOKINE-ACTIVATED KILLER ACTIVITY IN CANINE LYMPHOCYTES WITH LOW HUMAN RECOMBINANT INTERLEUKIN-2 IN-VITRO
Authors: HELFAND SC SOERGEL SA MODIANO JF HANK JA SONDEL PM
Citation: Sc. Helfand et al., INDUCTION OF LYMPHOKINE-ACTIVATED KILLER ACTIVITY IN CANINE LYMPHOCYTES WITH LOW HUMAN RECOMBINANT INTERLEUKIN-2 IN-VITRO, Cancer biotherapy, 9(3), 1994, pp. 237-244
COMPARISON OF 3 TREATMENTS FOR TRANSITIONAL-CELL CARCINOMA OF THE BLADDER IN THE DOG
Authors: HELFAND SC HAMILTON TA HUNGERFORD LL JEGLUM KA GOLDSCHMIDT MA
Citation: Sc. Helfand et al., COMPARISON OF 3 TREATMENTS FOR TRANSITIONAL-CELL CARCINOMA OF THE BLADDER IN THE DOG, The Journal of the American Animal Hospital Association, 30(3), 1994, pp. 270-275
CLINICAL AND IMMUNOLOGICAL EFFECTS OF HUMAN RECOMBINANT INTERLEUKIN-2GIVEN BY REPETITIVE WEEKLY INFUSION TO NORMAL DOGS
Authors: HELFAND SC SOERGEL SA MACWILLIAMS PS HANK JA SONDEL PM
Citation: Sc. Helfand et al., CLINICAL AND IMMUNOLOGICAL EFFECTS OF HUMAN RECOMBINANT INTERLEUKIN-2GIVEN BY REPETITIVE WEEKLY INFUSION TO NORMAL DOGS, Cancer immunology and immunotherapy, 39(2), 1994, pp. 84-92
PRIMARY ERYTHROCYTOSIS IN THE CAT - TREATMENT WITH HYDROXYUREA
Authors: WATSON ADJ MOORE AS HELFAND SC
Citation: Adj. Watson et al., PRIMARY ERYTHROCYTOSIS IN THE CAT - TREATMENT WITH HYDROXYUREA, Journal of Small Animal Practice, 35(6), 1994, pp. 320-325
PRIMARY IGG SECRETING PLASMA-CELL TUMOR IN THE GASTROINTESTINAL-TRACTOF A DOG
Authors: JACKSON MW HELFAND SC SMEDES SL BRADLEY GA SCHULTZ RD
Citation: Mw. Jackson et al., PRIMARY IGG SECRETING PLASMA-CELL TUMOR IN THE GASTROINTESTINAL-TRACTOF A DOG, Journal of the American Veterinary Medical Association, 204(3), 1994, pp. 404-406
CHEMOTHERAPY OF CANINE HEMANGIOSARCOMA WITH DOXORUBICIN AND CYCLOPHOSPHAMIDE
Authors: SORENMO KU JEGLUM KA HELFAND SC
Citation: Ku. Sorenmo et al., CHEMOTHERAPY OF CANINE HEMANGIOSARCOMA WITH DOXORUBICIN AND CYCLOPHOSPHAMIDE, Journal of veterinary internal medicine, 7(6), 1993, pp. 370-376
EVALUATION OF PROGNOSTIC FACTORS AND SEQUENTIAL COMBINATION CHEMOTHERAPY WITH DOXORUBICIN FOR CANINE LYMPHOMA
Authors: KELLER ET MACEWEN EG ROSENTHAL RC HELFAND SC FOX LE
Citation: Et. Keller et al., EVALUATION OF PROGNOSTIC FACTORS AND SEQUENTIAL COMBINATION CHEMOTHERAPY WITH DOXORUBICIN FOR CANINE LYMPHOMA, Journal of veterinary internal medicine, 7(5), 1993, pp. 289-295
RECENT ADVANCES IN THE BIOLOGIC THERAPY OF CANCER
Authors: MACEWEN EG HELFAND SC
Citation: Eg. Macewen et Sc. Helfand, RECENT ADVANCES IN THE BIOLOGIC THERAPY OF CANCER, The Compendium on continuing education for the practicing veterinarian, 15(7), 1993, pp. 909
Risultati: 1-17 |